136846-20-3,
(-)-(2S,5S)-1-(2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine,
4-amino-1-[(2S,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one,
2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2S-trans)-,
Lamivudine, (+/-)-trans-,
2'-Epi-Lamivudine,
OxathiolanC-(-)-alpha,
(+/-)-trans-Lamivudine,
Lamivudine impurity B [USP],
(-)-(2S,5S)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine,
Lamivudine impurity B RS [USP],
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-trans)-,
Lamivudine specified impurity B [EP],
OxathiolanC-(-).a.,
CHEMBL89149,
(?)-alpha-D-BCH-189,
SCHEMBL2305925,
AC1O7196,
ZINC16952920,
AKOS030528301,
2(1H)-Pyrimidinone, 4-amino-1-((2R,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, rel-,
2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, trans-,
4-Amino-1-((2RS,5RS)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one,
131086-22-1,
2 inverted exclamation mark -Epi-Lamivudine,
FT-0667904,
Lamivudine Impurity 4 (Lamivudine Diastereoisomer),
UNII-77ANF82R6X component JTEGQNOMFQHVDC-BQBZGAKWSA-N,
trans(-)-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane,
(2S-trans)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone,
4-Amino-1-[(2S,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone,
lamivudine,
UNII-77ANF82R6X,
77ANF82R6X,
CID6540852,